PiNgi
banner
pingi.bsky.social
PiNgi
@pingi.bsky.social
My life revolves mainly around all things related to Psychology & Psychotherapy.

Main interests:
Reading • Music • Food • Chelsea FC • Astrology

Catholic • HSP • Survivor • Forever learner • Demiromantic

Clinical Psychologist | She/her

📍🇱🇰
HAPPY NEW YEAR to everyone here!! ✨

Hope 2025 is a year filled with joy, growth, love, and immense success for you all.

Looking forward to more interactions with people in the future. ❤️
January 1, 2025 at 4:27 AM
Reposted by PiNgi
Doomscrolling with no ads is good
November 13, 2024 at 11:15 AM
It never gets easier, no matter how many times I've gone through this gruelling process.

For once, I was hoping to never have to repeat this again. Sigh.
November 19, 2024 at 5:40 PM
The one good thing about being forced to take bedrest this week is that I've been able to binge watch seasons of Schitts Creek.

I can't believe I didn't watch this sooner. It's so wholesome. 🥹💙
November 19, 2024 at 4:24 PM
I had forgotten about my Bluesky account for a while!

But since it's gaining traction again, I'm back. Hopefully, it'll be more active than it was before.
November 16, 2024 at 6:00 PM
Love this nifty summary of books read in 2023, thanks to @thestorygraph.com .

Here's to many more books happily consumed during 2024!
January 2, 2024 at 5:06 PM
I almost forgot about BlueSky cuz the last month has been an absolute blur with my dissertation submission.

Hopefully I can be more active here this year!

On that note, Happy New Year to you all! ✨
January 2, 2024 at 4:48 PM
Kinda forgot about this app's existence for a bit!

Should seriously switch to this while I'm overwhelmed by everything happening on Twitter.
November 3, 2023 at 12:43 PM
Reposted by PiNgi
🧪
About 2.8 million Americans suffer from schizophrenia (~24 million worldwide), with large portion of non-responders to available therapies.

KarXT offers a new mechanism of action (acts on acetylcholine vs dopamine) and has fewer side effects.
Karuna submits schizophrenia drug for US approval
The drug’s success in two late-stage clinical trials has buoyed Karuna to a market valuation exceeding $6 billion.
www.biopharmadive.com
September 28, 2023 at 11:49 PM
I like how I have limited people I'm following here, and who follow me back. It's like a reset.

Having had a Twitter account for 13+ years, it sucks to see how it's become a cesspit over the last 5 years or so. Honestly, sometimes I get tired of scrolling through the posts cuz of the toxicity.
September 29, 2023 at 4:01 AM
Reposted by PiNgi
September 23, 2023 at 9:09 AM
First "post" here!

I guess this is where I'll migrate to permanently once Twitter (no, I refuse to call it X) crashes and gets buried eventually.
September 27, 2023 at 6:07 PM